On the recordApril 30, 2019
Madam Speaker, I rise today to highlight the staggering cost of insulin. A study published last September estimated that manufacturers could charge between $7 and $11 for insulin and still make a profit. In reality, Madam Speaker, the list price today is $275 a vial. This is an unconscionable markup on a critical, lifesaving drug, as diabetes is the primary cause of death for 85,000 Americans each and every year. While insurance covers some of the costs, insulin is, all too often, unaffordable for the 17,000 Medicare beneficiaries in my district who depend on it to survive. That is because it can cost a senior on Medicare living in my hometown over $1,400 a year to pay for their diabetes medication. To combat this issue, I introduced the Insulin Access for All Act. My legislation ensures that Medicare and Medicaid recipients pay nothing out of pocket for their insulin. I urge my colleagues to join with me in reducing the cost of insulin for all Americans. ____________________





